<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Health Сare of the Russian Federation</journal-id><journal-title-group><journal-title xml:lang="en">Health Сare of the Russian Federation</journal-title><trans-title-group xml:lang="ru"><trans-title>Здравоохранение Российской Федерации</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0044-197X</issn><issn publication-format="electronic">2412-0723</issn><publisher><publisher-name xml:lang="en">Federal Scientific Center for Hygiene F.F.Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">637571</article-id><article-id pub-id-type="doi">10.18821/0044-197Х-2017-61-5-269-275</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>PROFESSION AND HEALTH</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ПРОФЕССИЯ И ЗДОРОВЬЕ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE INDICES OF MORBIDITY OF PANCREAS CANCER IN WORKERS OF RADIATION DANGEROUS ENTERPRISE</article-title><trans-title-group xml:lang="ru"><trans-title>ПОКАЗАТЕЛИ ЗАБОЛЕВАЕМОСТИ РАКОМ ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ У РАБОТНИКОВ РАДИАЦИОННО ОПАСНОГО ПРЕДПРИЯТИЯ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhuntova</surname><given-names>G. V.</given-names></name><name xml:lang="ru"><surname>Жунтова</surname><given-names>Г. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Azizova</surname><given-names>T. V.</given-names></name><name xml:lang="ru"><surname>Азизова</surname><given-names>Т. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>clinic@subi.su</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Grigor’Eva</surname><given-names>E. S.</given-names></name><name xml:lang="ru"><surname>Григорьева</surname><given-names>Е. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zavarukhina</surname><given-names>T. P.</given-names></name><name xml:lang="ru"><surname>Заварухина</surname><given-names>Т. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fomin</surname><given-names>E. P.</given-names></name><name xml:lang="ru"><surname>Фомин</surname><given-names>Е. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Southern Ural Institute of Biophysics</institution></aff><aff><institution xml:lang="ru">ФГУП «Южно-Уральский институт биофизики» ФМБА России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">The central medical sanitary unit №71</institution></aff><aff><institution xml:lang="ru">ФГБУЗ «Центральная медико-санитарная часть № 71» ФМБА России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-10-16" publication-format="electronic"><day>16</day><month>10</month><year>2017</year></pub-date><volume>61</volume><issue>5</issue><issue-title xml:lang="ru"/><fpage>269</fpage><lpage>275</lpage><history><date date-type="received" iso-8601-date="2024-10-25"><day>25</day><month>10</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Zhuntova G.V., Azizova T.V., Grigor’Eva E.S., Zavarukhina T.P., Fomin E.P.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Жунтова Г.В., Азизова Т.В., Григорьева Е.С., Заварухина Т.П., Фомин Е.П.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Zhuntova G.V., Azizova T.V., Grigor’Eva E.S., Zavarukhina T.P., Fomin E.P.</copyright-holder><copyright-holder xml:lang="ru">Жунтова Г.В., Азизова Т.В., Григорьева Е.С., Заварухина Т.П., Фомин Е.П.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/0044-197X/article/view/637571">https://journals.eco-vector.com/0044-197X/article/view/637571</self-uri><abstract xml:lang="en"><p>In Russia, during last decades increasing of morbidity of pancreas cancer is observed. This disease is among leading causes in the structure of mortality of malignant neoplasms. The data concerning effect of ionizing irradiation on development of pancreas cancer is ambiguous. The analysis was carried out concerning indices of morbidity of pancreas cancer in cohort of workers for the first time hired to enterprise of nuclear industry production association «Mayak» in 1948-1982 exposed to prolonged total external gamma-irradiation and internal alpha-irradiation by incorporated plutonium. It is established that in both considered cohort and total population, indices of morbidity of pancreas cancer depended on such non-radiation factors as attained age, gender, calendar period of observation, smoking and value of smoking index, alcohol abuse. The study established increasing of standardized by age indices of morbidity of pancreas cancer in workers exposed to prolonged external gamma-irradiation in doses 0.5 Gy and higher. The effect of internal alpha-irradiation on indices of morbidity of pancreas cancer was absent in examined cohort.</p></abstract><trans-abstract xml:lang="ru"><p>В последние десятилетия в Российской Федерации отмечается рост заболеваемости раком поджелудочной железы (ПЖ). Рак ПЖ входит в число ведущих причин в структуре смертности от злокачественных новообразований. Данные о влиянии ионизирующего излучения на возникновение рака ПЖ неоднозначны. Исследованы показатели заболеваемости раком ПЖ в когорте работников, впервые нанятых на предприятие атомной промышленности «Производственное объединение "Маяк"» в 1948-1982 гг., подвергшихся пролонгированному общему внешнему гамма-облучению и внутреннему альфа-облучению инкорпорированным плутонием. Установлено, что в изучаемой когорте, как и в общей популяции, показатели заболеваемости раком ПЖ зависели от нерадиационных факторов: достигнутый возраст, пол, календарный период наблюдения, курение и величина индекса курения, злоупотребление алкоголем. Обнаружено увеличение стандартизованных по возрасту показателей заболеваемости раком ПЖ у работников, подвергшихся пролонгированному внешнему гамма-облучению в дозах 0,5 Гр и более. Влияния внутреннего альфа-облучения на показатели заболеваемости раком ПЖ в изучаемой когорте не выявлено.</p></trans-abstract><kwd-group xml:lang="en"><kwd>pancreas cancer</kwd><kwd>external gamma-irradiation</kwd><kwd>internal alpha-irradiation</kwd><kwd>smoking</kwd><kwd>alcohol consumption</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак поджелудочной железы</kwd><kwd>внешнее гамма-облучение</kwd><kwd>внутреннее альфа-облучение</kwd><kwd>курение</kwd><kwd>употребление алкоголя</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T. et al. Cancer statistics, 2008. CA Cancer J. Clin. 2008; 58(2): 71-96.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Iovanna J., Mallmann M.C., Gonçalves A., Turrini O., Dagorn J.C. Current knowledge on pancreatic cancer. Front. Oncol. 2012; 2: 6.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2013 году (Заболеваемость и смертность). М: МНИОИ им. П.А. Герцена; 2015</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Vincent A., Herman J., Schulick R., Hruban R.H., Goggins M. Pancreatic cancer. Lancet. 2011; 378(9791): 607-20.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bosetti C., Lucenteforte E., Silverman D.T, Petersen G., Bracci P.M., Ji B.T. et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann. Oncol. 2012; 23(7): 1880-8.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Tramacere I., Scotti L., Jenab M., Bagnardi V., Bellocco R., Rota M. et al. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int. J. Cancer. 2010; 126(6): 1474-86.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Bosetti C., Rosato V., Li D., Silverman D., Petersen G.M., Bracci P.M. et al. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-control Consortium. Ann. Oncol. 2014; 25(10): 2065-72.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Maisonneuve P., Lowenfels A.B. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int. J. Epidemiol. 2015; 44(1): 186-98.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Klein A.P. Genetic susceptibility to pancreatic cancer. Mol. Carcinog. 2012; 51(1): 14-24.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ojajärvi I.A., Partanen T.J., Ahlbom A., Boffetta P., Hakulinen T., Jourenkova N. et al. Occupational exposures and pancreatic cancer: a meta-analysis. Occup. Environ. Med. 2000; 57(5): 316-24.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ozasa K., Shimizu Y., Suyama A., Kasagi F., Soda M., Grant E.J. et al. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat. Res. 2012; 177(3): 229-43.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Preston D., Ron E., Tokuoka S., Funamoto S., Nishi N., Soda M. et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 2007; 168(1): 1-64.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Dropkin G. Reanalysis of cancer mortality in Japanese A-bomb survivors exposed to low doses of radiation: bootstrap and simulation methods. Environ. Health. 2009; 8: 56.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Carr Z.A., Kleinerman R.A., Stovall M., Weinstock R.M., Griem M.L., Land С.E. Malignant neoplasms after radiation therapy for peptic ulcer. Radiat. Res. 2002; 157(6): 668-77.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Boice J.D. Jr., Engholm G., Kleinerman R.A., Blettner M., Stovall M., Lisco H. et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat. Res. 1988; 116(1): 3-55.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Little M.P., Stovall M., Smith S.A., Kleinerman R.A. A reanalysis of curvature in the dose response for cancer and modifications by age at exposure following radiotherapy for benign disease. Int. J. Radiat. Oncol. Biol. Phys. 2013; 85(2): 451-9.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Travis L.B., Hauptmann M., Gaul L.K., Storm H.H., Goldman M.B., Nyberg U., et al. Site-specific cancer incidence and mortality after cerebral angiography with radioactive Thorotrast. Radiat. Res. 2003; 160(6): 691-706.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Nyberg U., Nilsson B., Travis L.B., Holm L.E., Hall P. Cancer incidence among Swedish patients exposed to radioactive thorotrast: a forty-year follow-up survey. Radiat. Res. 2002; 157(4): 419-25.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Polednak A.P., Stehney A.F., Lucas H.F. Mortality among male workers at a thorium processing plant. Health Phys. 1983; 4(Suppl. 1): 239-51.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Cardis E., Vrijheid M., Blettner M., Gilbert E., Hakama M., Hill C. et al. The 15-country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat. Res. 2007; 167(4): 396-416.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Sokolnikov M.E., Gilbert E.S., Preston D.L., Ron E., Shilnikova N.S., Khokhryakov V.V. et al. Lung, liver and bone cancer mortality in Mayak workers. Int. J. Cancer. 2008; 123(4): 905-11.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Azizova T.V., Day R.D., Wald N., Muirhead C.R., O'Hagan J.A., Sumina M.V. et al. The «clinic» medical-dosimetric database of Mayak production association workers: structure, characteristics and prospects of utilization. Health. Phys. 2008; 94: 449-58.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Vasilenko E.K., Scherpelz R.I., Gorelov M.V., Stram D.J., Smetanin M.Y. External dosimetry reconstruction for Mayak workers. AAHP Special Session Health Physics Society Annual Meeting Paper. Salt Lake City; 2010. Available at: http://www.hps1.org/aahp/public/AAHP_Special_Sessions/2010_Salt_Lake_City/pm-1.pdf</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Dorrian M.D., Birchall A., Vostrotin V.V. Mayak Worker Dosimetry System (MWDS-2013): Phase I - Quality Assurance of Organ Doses and Excretion Rates from Internal Exposures of Plutonium-239 for the Mayak Worker Cohort. Radiat. Prot. Dosimetry. 2016; 1-16.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Мерков А.М., Поляков Л.Е. Санитарная статистика (Пособие для врачей). М.: Атомиздат; 1975</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Blackford A., Parmigiani G., Kensler T.W., Wolfgang C., Jones S., Zhang X. et al. Genetic mutations associated with cigarette smoking in pancreatic cancer. Cancer Res. 2009; 69(8): 3681-8.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Herreros-Villanueva M., Hijona E., Bañales J.M., Cosme A., Bujanda L. Alcohol consumption on pancreatic diseases. World J. Gastroenterol. 2013; 19(5): 638-47.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Shuryak I., Hahnfeldt P., Hlatky L., Sachs R.K., Brenner D.J. A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. Radiat. Environ. Biophys. 2009; 48(3): 275-86.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Hunter N., Kuznetsova I.S., Labutina E.V., Harrison J.D. Solid cancer incidence other than lung, liver and bone in Mayak workers: 1948-2004. Br. J. Cancer. 2013; 109(7): 1989-96.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Sokolnikov M., Preston D., Gilbert E., Schonfeld S., Koshurnikova N. Radiation Effects on Mortality from Solid Cancers Other than Lung, Liver, and Bone Cancer in the Mayak Worker Cohort: 1948-2008. PLoS One. 2015; 10(2): e0117784.</mixed-citation></ref></ref-list></back></article>
